Your browser doesn't support javascript.
loading
Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell.
Girkin, Jason L N; Maltby, Steven; Bartlett, Nathan W.
Affiliation
  • Girkin JLN; Viral Immunology and Respiratory Disease Group, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.
  • Maltby S; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.
  • Bartlett NW; Priority Research Centre for Healthy Lungs, University of Newcastle and Hunter Medical Research Institute, Newcastle, Australia.
Eur Respir Rev ; 31(164)2022 Jun 30.
Article in En | MEDLINE | ID: mdl-35508333
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: Eur Respir Rev Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Limits: Humans Language: En Journal: Eur Respir Rev Year: 2022 Document type: Article Affiliation country: Country of publication: